Genistein chemoprevention of prostate cancer in TRAMP mice
about
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayCharacterization of SV-40 Tag rats as a model to study prostate cancer.Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancerChemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal modelsThe Ron receptor promotes prostate tumor growth in the TRAMP mouse model.Plasma genistein and risk of prostate cancer in Chinese population.The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells.Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP miceCombination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer.Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents.The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model.Systemic buffers inhibit carcinogenesis in TRAMP miceXeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor.Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics.Advances in mouse models of prostate cancer.Soy Saponins Meditate the Progression of Colon Cancer in Rats by Inhibiting the Activity of β -Glucuronidase and the Number of Aberrant Crypt Foci but Not Cyclooxygenase-2 Activity.Future directions in the prevention of prostate cancer.Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.Prevention of prostate cancer: what we know and where we are going.Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.Soy isoflavones and prostate cancer: a review of molecular mechanisms.Risks and benefits of dietary isoflavones for cancer.The role of murine models of prostate cancer in drug target discovery and validation.The strategies to control prostate cancer by chemoprevention approaches.Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2.Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.Basal cell induced differentiation of noncancerous prostate epithelial cells (RWPE-1) by glycitein.Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidenceMicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancerOral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model.The prooxidant action of dietary antioxidants leading to cellular DNA breakage and anticancer effects: implications for chemotherapeutic action against cancer.Progesterone as a morphological regulatory factor of the male and female gerbil prostate.Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis.Effect of germinated soy protein on the growth of HeLa cervical cancer cells in female athymic mice.
P2860
Q28382812-AFBF483D-E07C-4ACD-A7FA-579808CA3E0BQ33403060-DDB7F765-7D40-4E5C-AE8D-A2E67891B1AEQ33787995-9D752F2C-20E5-4EB8-B372-E5E1010993DEQ35014332-EC31C537-B4E8-4438-ACC4-331FC98C3174Q35190869-91649E13-F5A8-4D46-8288-770E73CBC6DCQ35651999-FAB42330-A5C8-41E1-9CC7-2CDCB43CD798Q35850102-3B2C8E52-9CA7-4084-AC22-757B3528EDACQ36177446-3D3D41BB-3CFB-4594-92A2-B5179BB13AD6Q36238826-BA2FD108-2792-4C99-ABB5-8874DE4FEAFCQ36566654-222A914C-024C-4615-838E-174BD4B388F6Q36924955-1B202496-0B07-4EDF-BD42-343840C4B301Q36960515-49E74DD0-1A16-4604-80A9-FD72A54A0422Q37084688-677DCCC1-D048-4000-822A-AB6C6AFB3909Q37173328-179A6BA7-1CF3-480B-9081-1D7081E6F2F2Q37185527-166EE755-41B8-4A89-BB7E-A0AA6D9BE0EEQ37256288-43D469F3-F05E-4708-AC73-ED5B40358FFBQ37279094-B7B9E990-84FD-4035-ADD6-954F26334952Q37379774-3CD3402D-E962-4D7D-8F04-E153687CBD0FQ37499593-E1A92A2B-4A55-494D-BF44-6A390E882DB0Q37577822-C64D7954-69E6-4E56-924F-B6CCD5658F7CQ37654590-EC332902-9AA7-44BD-B008-D45FF14A647AQ37857841-28FB29CC-EF1D-4579-BD57-14D479A63E58Q38089910-937C3375-0E04-4307-AB50-38C7C099EDD0Q38175776-F8F1431E-A7B2-4078-87DD-B64663CB972EQ38762796-51E61EA0-8DC6-4E8A-B261-D0D065A548E2Q38777429-6B99DCFD-72AF-4D1A-B76A-54747E2DBC46Q38935085-C3EA6CD9-8F9F-4609-9E54-1E5E32583C8AQ39859906-01FC5149-F4ED-473A-91AC-5D5A9A78EAB8Q39924579-CEFCA39A-B9A3-41C5-B406-1F69FA36A5BCQ41412852-04E55A3D-B3A4-477B-BEF0-C8227B09AC75Q42137006-BB7CA0DD-EFF3-4CAA-BECF-CA51D0079CAFQ44633996-1B74DD29-155B-4878-B8DD-7D762F8B083AQ45423679-F58597D2-1C50-4EE4-AB99-C1AA1544292AQ50956092-ACA2FE96-6813-4794-B73B-74C95FCCA4D6Q51295456-FD7BFA32-DCDB-4316-A40A-F64FFC238916
P2860
Genistein chemoprevention of prostate cancer in TRAMP mice
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genistein chemoprevention of prostate cancer in TRAMP mice
@ast
Genistein chemoprevention of prostate cancer in TRAMP mice
@en
type
label
Genistein chemoprevention of prostate cancer in TRAMP mice
@ast
Genistein chemoprevention of prostate cancer in TRAMP mice
@en
prefLabel
Genistein chemoprevention of prostate cancer in TRAMP mice
@ast
Genistein chemoprevention of prostate cancer in TRAMP mice
@en
P2093
P2860
P356
P1476
Genistein chemoprevention of prostate cancer in TRAMP mice
@en
P2093
Coral A Lamartiniere
Isam-Eldin Eltoum
P2860
P356
10.1186/1477-3163-6-3
P407
P577
2007-03-16T00:00:00Z